+1 347 708 0418
The Acute Myeloid Leukemia market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Acute Myeloid Leukemia size is estimated to be USD 2145.6 million in 2026 from USD 1342.3 million in 2020, with a change XX% between 2020 and 2021. The global Acute Myeloid Leukemia market size is expected to grow at a CAGR of 12.4% for the next five years.
Market segmentation
Acute Myeloid Leukemia market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chemotherapy
Radiation Therapy
Stem Cell Transplant
Targeted Therapy
Others
Market segment by Application, can be divided into
Hospital
Retails Drug Stores
Ambulatory Care Centers
Oncology Centers
Clinics
Market segment by players, this report covers
Celgene Corporation
Cephalon
Clavis Pharma
Eisai
Genzyme Corporation
Sunesis Pharmaceuticals
Abbvie
Astellas Pharma
CTI Biopharma Corp
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Acute Myeloid Leukemia product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Acute Myeloid Leukemia, with revenue, gross margin and global market share of Acute Myeloid Leukemia from 2019 to 2021.
Chapter 3, the Acute Myeloid Leukemia competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Acute Myeloid Leukemia market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Acute Myeloid Leukemia research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Acute Myeloid Leukemia
1.2 Classification of Acute Myeloid Leukemia by Type
1.2.1 Overview: Global Acute Myeloid Leukemia Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Acute Myeloid Leukemia Revenue Market Share by Type in 2020
1.2.3 Chemotherapy
1.2.4 Radiation Therapy
1.2.5 Stem Cell Transplant
1.2.6 Targeted Therapy
1.2.7 Others
1.3 Global Acute Myeloid Leukemia Market by Application
1.3.1 Overview: Global Acute Myeloid Leukemia Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Retails Drug Stores
1.3.4 Ambulatory Care Centers
1.3.5 Oncology Centers
1.3.6 Clinics
1.4 Global Acute Myeloid Leukemia Market Size & Forecast
1.5 Global Acute Myeloid Leukemia Market Size and Forecast by Region
1.5.1 Global Acute Myeloid Leukemia Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Acute Myeloid Leukemia Market Size by Region, (2016-2021)
1.5.3 North America Acute Myeloid Leukemia Market Size and Prospect (2016-2026)
1.5.4 Europe Acute Myeloid Leukemia Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Acute Myeloid Leukemia Market Size and Prospect (2016-2026)
1.5.6 South America Acute Myeloid Leukemia Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Acute Myeloid Leukemia Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Acute Myeloid Leukemia Market Drivers
1.6.2 Acute Myeloid Leukemia Market Restraints
1.6.3 Acute Myeloid Leukemia Trends Analysis
2 Company Profiles
2.1 Celgene Corporation
2.1.1 Celgene Corporation Details
2.1.2 Celgene Corporation Major Business
2.1.3 Celgene Corporation Acute Myeloid Leukemia Product and Solutions
2.1.4 Celgene Corporation Acute Myeloid Leukemia Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Celgene Corporation Recent Developments and Future Plans
2.2 Cephalon
2.2.1 Cephalon Details
2.2.2 Cephalon Major Business
2.2.3 Cephalon Acute Myeloid Leukemia Product and Solutions
2.2.4 Cephalon Acute Myeloid Leukemia Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Cephalon Recent Developments and Future Plans
2.3 Clavis Pharma
2.3.1 Clavis Pharma Details
2.3.2 Clavis Pharma Major Business
2.3.3 Clavis Pharma Acute Myeloid Leukemia Product and Solutions
2.3.4 Clavis Pharma Acute Myeloid Leukemia Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Clavis Pharma Recent Developments and Future Plans
2.4 Eisai
2.4.1 Eisai Details
2.4.2 Eisai Major Business
2.4.3 Eisai Acute Myeloid Leukemia Product and Solutions
2.4.4 Eisai Acute Myeloid Leukemia Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Eisai Recent Developments and Future Plans
2.5 Genzyme Corporation
2.5.1 Genzyme Corporation Details
2.5.2 Genzyme Corporation Major Business
2.5.3 Genzyme Corporation Acute Myeloid Leukemia Product and Solutions
2.5.4 Genzyme Corporation Acute Myeloid Leukemia Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Genzyme Corporation Recent Developments and Future Plans
2.6 Sunesis Pharmaceuticals
2.6.1 Sunesis Pharmaceuticals Details
2.6.2 Sunesis Pharmaceuticals Major Business
2.6.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Product and Solutions
2.6.4 Sunesis Pharmaceuticals Acute Myeloid Leukemia Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Sunesis Pharmaceuticals Recent Developments and Future Plans
2.7 Abbvie
2.7.1 Abbvie Details
2.7.2 Abbvie Major Business
2.7.3 Abbvie Acute Myeloid Leukemia Product and Solutions
2.7.4 Abbvie Acute Myeloid Leukemia Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Abbvie Recent Developments and Future Plans
2.8 Astellas Pharma
2.8.1 Astellas Pharma Details
2.8.2 Astellas Pharma Major Business
2.8.3 Astellas Pharma Acute Myeloid Leukemia Product and Solutions
2.8.4 Astellas Pharma Acute Myeloid Leukemia Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Astellas Pharma Recent Developments and Future Plans
2.9 CTI Biopharma Corp
2.9.1 CTI Biopharma Corp Details
2.9.2 CTI Biopharma Corp Major Business
2.9.3 CTI Biopharma Corp Acute Myeloid Leukemia Product and Solutions
2.9.4 CTI Biopharma Corp Acute Myeloid Leukemia Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 CTI Biopharma Corp Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Acute Myeloid Leukemia Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Acute Myeloid Leukemia Players Market Share
3.2.2 Top 10 Acute Myeloid Leukemia Players Market Share
3.2.3 Market Competition Trend
3.3 Acute Myeloid Leukemia Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Acute Myeloid Leukemia Revenue and Market Share by Type (2016-2021)
4.2 Global Acute Myeloid Leukemia Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Acute Myeloid Leukemia Revenue Market Share by Application (2016-2021)
5.2 Acute Myeloid Leukemia Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Acute Myeloid Leukemia Revenue by Type (2016-2026)
6.2 North America Acute Myeloid Leukemia Revenue by Application (2016-2026)
6.3 North America Acute Myeloid Leukemia Market Size by Country
6.3.1 North America Acute Myeloid Leukemia Revenue by Country (2016-2026)
6.3.2 United States Acute Myeloid Leukemia Market Size and Forecast (2016-2026)
6.3.3 Canada Acute Myeloid Leukemia Market Size and Forecast (2016-2026)
6.3.4 Mexico Acute Myeloid Leukemia Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Acute Myeloid Leukemia Revenue by Type (2016-2026)
7.2 Europe Acute Myeloid Leukemia Revenue by Application (2016-2026)
7.3 Europe Acute Myeloid Leukemia Market Size by Country
7.3.1 Europe Acute Myeloid Leukemia Revenue by Country (2016-2026)
7.3.2 Germany Acute Myeloid Leukemia Market Size and Forecast (2016-2026)
7.3.3 France Acute Myeloid Leukemia Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Acute Myeloid Leukemia Market Size and Forecast (2016-2026)
7.3.5 Russia Acute Myeloid Leukemia Market Size and Forecast (2016-2026)
7.3.6 Italy Acute Myeloid Leukemia Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Acute Myeloid Leukemia Revenue by Type (2016-2026)
8.2 Asia-Pacific Acute Myeloid Leukemia Revenue by Application (2016-2026)
8.3 Asia-Pacific Acute Myeloid Leukemia Market Size by Region
8.3.1 Asia-Pacific Acute Myeloid Leukemia Revenue by Region (2016-2026)
8.3.2 China Acute Myeloid Leukemia Market Size and Forecast (2016-2026)
8.3.3 Japan Acute Myeloid Leukemia Market Size and Forecast (2016-2026)
8.3.4 South Korea Acute Myeloid Leukemia Market Size and Forecast (2016-2026)
8.3.5 India Acute Myeloid Leukemia Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Acute Myeloid Leukemia Market Size and Forecast (2016-2026)
8.3.7 Australia Acute Myeloid Leukemia Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Acute Myeloid Leukemia Revenue by Type (2016-2026)
9.2 South America Acute Myeloid Leukemia Revenue by Application (2016-2026)
9.3 South America Acute Myeloid Leukemia Market Size by Country
9.3.1 South America Acute Myeloid Leukemia Revenue by Country (2016-2026)
9.3.2 Brazil Acute Myeloid Leukemia Market Size and Forecast (2016-2026)
9.3.3 Argentina Acute Myeloid Leukemia Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Acute Myeloid Leukemia Revenue by Type (2016-2026)
10.2 Middle East & Africa Acute Myeloid Leukemia Revenue by Application (2016-2026)
10.3 Middle East & Africa Acute Myeloid Leukemia Market Size by Country
10.3.1 Middle East & Africa Acute Myeloid Leukemia Revenue by Country (2016-2026)
10.3.2 Turkey Acute Myeloid Leukemia Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Acute Myeloid Leukemia Market Size and Forecast (2016-2026)
10.3.4 UAE Acute Myeloid Leukemia Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Acute Myeloid Leukemia Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Acute Myeloid Leukemia Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Acute Myeloid Leukemia Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Acute Myeloid Leukemia Revenue (USD Million) by Region (2016-2021)
Table 5. Global Acute Myeloid Leukemia Revenue Market Share by Region (2021-2026)
Table 6. Celgene Corporation Corporate Information, Head Office, and Major Competitors
Table 7. Celgene Corporation Major Business
Table 8. Celgene Corporation Acute Myeloid Leukemia Product and Solutions
Table 9. Celgene Corporation Acute Myeloid Leukemia Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Cephalon Corporate Information, Head Office, and Major Competitors
Table 11. Cephalon Major Business
Table 12. Cephalon Acute Myeloid Leukemia Product and Solutions
Table 13. Cephalon Acute Myeloid Leukemia Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Clavis Pharma Corporate Information, Head Office, and Major Competitors
Table 15. Clavis Pharma Major Business
Table 16. Clavis Pharma Acute Myeloid Leukemia Product and Solutions
Table 17. Clavis Pharma Acute Myeloid Leukemia Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Eisai Corporate Information, Head Office, and Major Competitors
Table 19. Eisai Major Business
Table 20. Eisai Acute Myeloid Leukemia Product and Solutions
Table 21. Eisai Acute Myeloid Leukemia Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Genzyme Corporation Corporate Information, Head Office, and Major Competitors
Table 23. Genzyme Corporation Major Business
Table 24. Genzyme Corporation Acute Myeloid Leukemia Product and Solutions
Table 25. Genzyme Corporation Acute Myeloid Leukemia Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Sunesis Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 27. Sunesis Pharmaceuticals Major Business
Table 28. Sunesis Pharmaceuticals Acute Myeloid Leukemia Product and Solutions
Table 29. Sunesis Pharmaceuticals Acute Myeloid Leukemia Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Abbvie Corporate Information, Head Office, and Major Competitors
Table 31. Abbvie Major Business
Table 32. Abbvie Acute Myeloid Leukemia Product and Solutions
Table 33. Abbvie Acute Myeloid Leukemia Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Astellas Pharma Corporate Information, Head Office, and Major Competitors
Table 35. Astellas Pharma Major Business
Table 36. Astellas Pharma Acute Myeloid Leukemia Product and Solutions
Table 37. Astellas Pharma Acute Myeloid Leukemia Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. CTI Biopharma Corp Corporate Information, Head Office, and Major Competitors
Table 39. CTI Biopharma Corp Major Business
Table 40. CTI Biopharma Corp Acute Myeloid Leukemia Product and Solutions
Table 41. CTI Biopharma Corp Acute Myeloid Leukemia Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Global Acute Myeloid Leukemia Revenue (USD Million) by Players (2019-2021)
Table 43. Global Acute Myeloid Leukemia Revenue Share by Players (2019-2021)
Table 44. Breakdown of Acute Myeloid Leukemia by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Acute Myeloid Leukemia Players Head Office, Products and Services Provided
Table 46. Acute Myeloid Leukemia Mergers & Acquisitions in the Past Five Years
Table 47. Acute Myeloid Leukemia New Entrants and Expansion Plans
Table 48. Global Acute Myeloid Leukemia Revenue (USD Million) by Type (2016-2021)
Table 49. Global Acute Myeloid Leukemia Revenue Share by Type (2016-2021)
Table 50. Global Acute Myeloid Leukemia Revenue Forecast by Type (2021-2026)
Table 51. Global Acute Myeloid Leukemia Revenue by Application (2016-2021)
Table 52. Global Acute Myeloid Leukemia Revenue Forecast by Application (2021-2026)
Table 53. North America Acute Myeloid Leukemia Revenue by Type (2016-2021) & (USD Million)
Table 54. North America Acute Myeloid Leukemia Revenue by Type (2021-2026) & (USD Million)
Table 55. North America Acute Myeloid Leukemia Revenue by Application (2016-2021) & (USD Million)
Table 56. North America Acute Myeloid Leukemia Revenue by Application (2021-2026) & (USD Million)
Table 57. North America Acute Myeloid Leukemia Revenue by Country (2016-2021) & (USD Million)
Table 58. North America Acute Myeloid Leukemia Revenue by Country (2021-2026) & (USD Million)
Table 59. Europe Acute Myeloid Leukemia Revenue by Type (2016-2021) & (USD Million)
Table 60. Europe Acute Myeloid Leukemia Revenue by Type (2021-2026) & (USD Million)
Table 61. Europe Acute Myeloid Leukemia Revenue by Application (2016-2021) & (USD Million)
Table 62. Europe Acute Myeloid Leukemia Revenue by Application (2021-2026) & (USD Million)
Table 63. Europe Acute Myeloid Leukemia Revenue by Country (2016-2021) & (USD Million)
Table 64. Europe Acute Myeloid Leukemia Revenue by Country (2021-2026) & (USD Million)
Table 65. Asia-Pacific Acute Myeloid Leukemia Revenue by Type (2016-2021) & (USD Million)
Table 66. Asia-Pacific Acute Myeloid Leukemia Revenue by Type (2021-2026) & (USD Million)
Table 67. Asia-Pacific Acute Myeloid Leukemia Revenue by Application (2016-2021) & (USD Million)
Table 68. Asia-Pacific Acute Myeloid Leukemia Revenue by Application (2021-2026) & (USD Million)
Table 69. Asia-Pacific Acute Myeloid Leukemia Revenue by Region (2016-2021) & (USD Million)
Table 70. Asia-Pacific Acute Myeloid Leukemia Revenue by Region (2021-2026) & (USD Million)
Table 71. South America Acute Myeloid Leukemia Revenue by Type (2016-2021) & (USD Million)
Table 72. South America Acute Myeloid Leukemia Revenue by Type (2021-2026) & (USD Million)
Table 73. South America Acute Myeloid Leukemia Revenue by Application (2016-2021) & (USD Million)
Table 74. South America Acute Myeloid Leukemia Revenue by Application (2021-2026) & (USD Million)
Table 75. South America Acute Myeloid Leukemia Revenue by Country (2016-2021) & (USD Million)
Table 76. South America Acute Myeloid Leukemia Revenue by Country (2021-2026) & (USD Million)
Table 77. Middle East & Africa Acute Myeloid Leukemia Revenue by Type (2016-2021) & (USD Million)
Table 78. Middle East & Africa Acute Myeloid Leukemia Revenue by Type (2021-2026) & (USD Million)
Table 79. Middle East & Africa Acute Myeloid Leukemia Revenue by Application (2016-2021) & (USD Million)
Table 80. Middle East & Africa Acute Myeloid Leukemia Revenue by Application (2021-2026) & (USD Million)
Table 81. Middle East & Africa Acute Myeloid Leukemia Revenue by Country (2016-2021) & (USD Million)
Table 82. Middle East & Africa Acute Myeloid Leukemia Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Acute Myeloid Leukemia Picture
Figure 2. Global Acute Myeloid Leukemia Revenue Market Share by Type in 2020
Figure 3. Chemotherapy
Figure 4. Radiation Therapy
Figure 5. Stem Cell Transplant
Figure 6. Targeted Therapy
Figure 7. Others
Figure 8. Acute Myeloid Leukemia Revenue Market Share by Application in 2020
Figure 9. Hospital Picture
Figure 10. Retails Drug Stores Picture
Figure 11. Ambulatory Care Centers Picture
Figure 12. Oncology Centers Picture
Figure 13. Clinics Picture
Figure 14. Global Acute Myeloid Leukemia Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 15. Global Acute Myeloid Leukemia Revenue and Forecast (2016-2026) & (USD Million)
Figure 16. Global Acute Myeloid Leukemia Revenue Market Share by Region (2016-2026)
Figure 17. Global Acute Myeloid Leukemia Revenue Market Share by Region in 2020
Figure 18. North America Acute Myeloid Leukemia Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Europe Acute Myeloid Leukemia Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Asia-Pacific Acute Myeloid Leukemia Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. South America Acute Myeloid Leukemia Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Middle East and Africa Acute Myeloid Leukemia Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. Acute Myeloid Leukemia Market Drivers
Figure 24. Acute Myeloid Leukemia Market Restraints
Figure 25. Acute Myeloid Leukemia Market Trends
Figure 26. Celgene Corporation Recent Developments and Future Plans
Figure 27. Cephalon Recent Developments and Future Plans
Figure 28. Clavis Pharma Recent Developments and Future Plans
Figure 29. Eisai Recent Developments and Future Plans
Figure 30. Genzyme Corporation Recent Developments and Future Plans
Figure 31. Sunesis Pharmaceuticals Recent Developments and Future Plans
Figure 32. Abbvie Recent Developments and Future Plans
Figure 33. Astellas Pharma Recent Developments and Future Plans
Figure 34. CTI Biopharma Corp Recent Developments and Future Plans
Figure 35. Global Acute Myeloid Leukemia Revenue Share by Players in 2020
Figure 36. Acute Myeloid Leukemia Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 37. Global Top 3 Players Acute Myeloid Leukemia Revenue Market Share in 2020
Figure 38. Global Top 10 Players Acute Myeloid Leukemia Revenue Market Share in 2020
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 40. Global Acute Myeloid Leukemia Revenue Share by Type in 2020
Figure 41. Global Acute Myeloid Leukemia Market Share Forecast by Type (2021-2026)
Figure 42. Global Acute Myeloid Leukemia Revenue Share by Application in 2020
Figure 43. Global Acute Myeloid Leukemia Market Share Forecast by Application (2021-2026)
Figure 44. North America Acute Myeloid Leukemia Sales Market Share by Type (2016-2026)
Figure 45. North America Acute Myeloid Leukemia Sales Market Share by Application (2016-2026)
Figure 46. North America Acute Myeloid Leukemia Revenue Market Share by Country (2016-2026)
Figure 47. United States Acute Myeloid Leukemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Canada Acute Myeloid Leukemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Mexico Acute Myeloid Leukemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Europe Acute Myeloid Leukemia Sales Market Share by Type (2016-2026)
Figure 51. Europe Acute Myeloid Leukemia Sales Market Share by Application (2016-2026)
Figure 52. Europe Acute Myeloid Leukemia Revenue Market Share by Country (2016-2026)
Figure 53. Germany Acute Myeloid Leukemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Acute Myeloid Leukemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Acute Myeloid Leukemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Acute Myeloid Leukemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Acute Myeloid Leukemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Acute Myeloid Leukemia Sales Market Share by Type (2016-2026)
Figure 59. Asia-Pacific Acute Myeloid Leukemia Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Acute Myeloid Leukemia Revenue Market Share by Region (2016-2026)
Figure 61. China Acute Myeloid Leukemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Acute Myeloid Leukemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South Korea Acute Myeloid Leukemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Acute Myeloid Leukemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Acute Myeloid Leukemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Acute Myeloid Leukemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Acute Myeloid Leukemia Sales Market Share by Type (2016-2026)
Figure 68. South America Acute Myeloid Leukemia Sales Market Share by Application (2016-2026)
Figure 69. South America Acute Myeloid Leukemia Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Acute Myeloid Leukemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Acute Myeloid Leukemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East and Africa Acute Myeloid Leukemia Sales Market Share by Type (2016-2026)
Figure 73. Middle East and Africa Acute Myeloid Leukemia Sales Market Share by Application (2016-2026)
Figure 74. Middle East and Africa Acute Myeloid Leukemia Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Acute Myeloid Leukemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Acute Myeloid Leukemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. UAE Acute Myeloid Leukemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source
Buy
